Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982541priorityCriticalpatent/ECSP982541A/en
Publication of ECSP982541ApublicationCriticalpatent/ECSP982541A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Un método para el tratamiento de diabetes mellitus y condiciones asociadas con diabetes mellitus en un mamífero, cuyo método comprende administrar una cantidad eficaz no tóxica y farmacéuticamente aceptable de un sensibilizador a insulina y un agente antihiperglucémico inhibidor de alfaglucosidasa, a un mamífero que necesita de ello.A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, the method of which comprises administering a non-toxic and pharmaceutically acceptable effective amount of an insulin sensitizer and an alpha-glucosidase inhibiting antihyperglycemic agent, to a mammal in need thereof. .
ECSP9825411998-06-171998-06-17
NEW METHOD OF TREATMENT II
ECSP982541A
(en)
USE OF AN INSULIN SENSITIZER AND AN ANTI-HYPERGLYCEMIC AGENT FOR THE PREPARATION OF A MEDICATION FOR THE TREATMENT OF DIABETES MELLITUS AND CONDITIONS ASSOCIATED WITH IT AND A PHARMACEUTICAL COMPOSITION.